SLV - iShares Silver Trust
| Previous Close | 16.46 |
| Open | 16.61 |
| Bid | 16.57 x 27000 |
| Ask | 16.58 x 301500 |
| Day's Range | 16.54 - 16.62 |
| 52 Week Range | 13.39 - 18.35 |
| Volume | 8,611,213 |
| Avg. Volume | 11,986,963 |
| Net Assets | 6.47B |
| NAV | 16.53 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Daily Total Return | -1.95% |
| Beta (5Y Monthly) | 0.09 |
| Expense Ratio (net) | 0.50% |
| Inception Date | 2006-04-21 |
- Insider Monkey
Gold vs. Platinum: Which Is A Better Investment?
Gold is the granddaddy of precious metals, at least from an investment perspective. But other precious metals such as platinum and silver have their own place in a savvy investor’s portfolio. They are tangible assets with intrinsic value. The Federal Reserve cannot print more of them. Both gold and platinum have their own unique qualities. In this […]
- Zacks
ETF Strategies to Combat Coronavirus Outbreak
The contagious coronavirus has rattled financial markets. We discuss some strategies to combat the outbreak.
- Investopedia
Market Risk Lurks
With volatility indexes trying to price in the risk of falling prices, precious metals prices pop, with palladium seeing demand.
- MoneyShow
Top Picks 2020- Three Favorite Gold Silver ETFs GLD GDX SLV
The gold related markets were outstanding in 2019. Gold shares were especially strong, leading the way for the entire sector, observe resource sector specialists Mary Anne and Pamela Aden, editors of The Aden Forecast.
- Market Exclusive
Market Morning: Stocks Worth $90T, Gold Jumps, Chinese Chicken Problems, El Erian Worries
Value Of Earth’s Stock Markets Reaches $90 Trillion Just $910 trillion to go before we have to start using the word “quadrillion” in reference to stock valuations. The dizzying number has a lot to do with central banks around the world, which continued to print money at breakneck speed for the 11th year since the […]The post Market Morning: Stocks Worth $90T, Gold Jumps, Chinese Chicken Problems, El Erian Worries appeared first on Market Exclusive.
- Investopedia
Markets Tight-Ranged Except for Silver and Gold
Stocks, bonds, currencies, and commodity markets traded nearly unchanged during the hours of yesterday's abbreviated session at the New York Stock Exchange. The price of silver and gold were notable exceptions, however, as these markets broke significantly higher. The price of silver rose nearly 2%, while gold increased by 1%.
- ETF Trends
5 ETFs to Consider When Volatility Spikes
The Cboe Volatility Index is widely used as an indicator of measuring the ebbs and flows of volatility in the markets. iShares Gold Trust (IAU) : seeks to reflect generally the performance of the price of gold and the performance before payment of the Trust’s expenses and liabilities. The Trust does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of gold.
- ETF Database
Buy on the Dip Prospects: December 4 Edition
Below is a look at ETFs that currently offer attractive buying opportunities. The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be in an uptrend based on the fact that its 50-day moving average is above its 200-day moving average, which are popular indicators for gauging long-term and medium-term trends, respectively. Second, each of these ETFs is also trading below its five-day moving average, thereby offering a near-term 'buy on the dip' opportunity, given the longer-term uptrend at hand. Note that this prospects list also features a liquidity screen by excluding ETFs with average trading volumes below the one million shares mark. As always, investors of all experience levels are advised to use stop-loss orders and practice disciplined profit-taking techniques. To get access to all ETFdb.com premium content, sign up for a free 14-day trial to ETFdb.com Pro.
- PR Newswire
Selvita Q3 2019 Results: Accelerated Growth, 45 Percent Increase in Commercial Revenues and Strong Long-term Outlook
KRAKÓW, Poland, Nov. 7, 2019 /PRNewswire/ -- Selvita (SLV.WA) - one of the largest preclinical contract research organizations in Europe – reported today third quarter 2019 financial results and provided a corporate update following a recent corporate split of the oncology therapeutics (Ryvu Therapeutics) and contract research (CRO) business units (Selvita). The services segment of the Company has recorded USD 5.59 million of commercial revenue in Q3 2019, which marks a 45% increase compared to Q3 2018. In the first three quarters of 2019, Selvita Group recorded USD 18.8 million of revenues, 32% increase comparing to the corresponding period in 2018.
- Zacks
Phase 1 Trade Deal or Not: ETFs to Ride the Trend
The fate of the 'phase 1' U.S.-China trade deal remains uncertain. In such a situation, we highlight some ETF strategies to ride out the trade volatility.
- Benzinga
Palladium ETF Continues Pushing Past Precious Metals Rivals
Lower interest rates and negative-yielding debt around the world are among the factors contributing to investors renewed interest in precious metals and the related exchange traded funds this year. When the conversation on precious metals ETF is reborn, it usually drifts toward funds such as the SPDR Gold Shares (NYSE: GLD) and the iShares Silver Trust (NYSE: SLV) due to silver's correlations to gold. Year to date, the Aberdeen Standard Physical Palladium Shares ETF (NYSE: PALL), which is backed by physical holdings of the white metal, is higher by more than 43%.
- Zacks
ETF Strategies to Follow Amid Recession Scares
We highlight a few ETF strategies in the wake of recessionary warnings.
- PR Newswire
Ryvu Therapeutics and Selvita Announce Registration of Corporate Split by the National Court Register of Poland
KRAKOW, Poland, Oct. 1, 2019 /PRNewswire/ -- Ryvu Therapeutics and Selvita (SLV.WA) today announced that the National Court Register of Poland ("KRS") has recognized the corporate split of the Selvita parent company into two distinct organizations. The recognition by the court follows the Sept. 19, 2019, shareholder resolution to separate oncology therapeutics and contract research (CRO) business units. Going forward, Ryvu Therapeutics and Selvita (CRO) will now operate independently with separate executive management teams as well as supervisory boards, in accordance with the shareholder resolution.
- PR Newswire
Selvita Announces Shareholder Approval of Corporate Split and New Name of Ryvu Therapeutics for Oncology Development Company
KRAKOW, Poland, Sept. 19, 2019 /PRNewswire/ -- Selvita (SLV.WA) today announced that following the Shareholder Meeting of the Company which took place today, shareholders have adopted a resolution to approve the plan to separate the Selvita oncology therapeutics and contract research business units into two independent companies. The therapeutics company, which will maintain public listing, will operate under the new name of Ryvu Therapeutics and focus on proprietary oncology drug discovery and development. Both companies will be independently listed on the Warsaw Stock Exchange following the completion of regulatory processes in the National Court Register ("KRS"), National Depository for Securities ("KDPW") and Warsaw Stock Exchange ("GPW").
- InvestorPlace
Stay Short in SPDR Gold Shares ETF
Gold is rare and people love it, so its price should always go up, right? But SPDR Gold Shares (NYSEARCA:GLD) has had an extended run that should slowly start to become less intense. So today's trade is GLD stock. The argument is not that it rose too much, because it still trails the S&P 500 year-to-date. The problem is that with the steepness of its wedge, its chart is vulnerable to dips.Source: Shutterstock This is nothing personal against the shiny metal, but nothing goes up in a straight line forever -- although the recent run in GLD, iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT) and iShares Silver Trust (NYSEARCA:SLV) was insane. Global investors chased those three up partly as a safe haven trade from geopolitical risk, and also because of the popular TINA acronym.Consensus is that there "there is no alternative" to buying U.S. Treasurys when global bonds yield negative rates. Not many are willing to buy investment vehicles that advertise guaranteed losses. So they buy U.S. bonds, gold and silver instead. This means GLD came along for the ride.InvestorPlace - Stock Market News, Stock Advice & Trading Tips There is Danger in Those Golden GLD Charts.There is no way I can quantify the value of gold. The stuff is in high demand and people love it. The only reason it has any value is because we say so. Furthermore, it is hard to extract and getting even rarer. Clearly the price should go up indefinitely.But the modern Wall Street is more predictable than in the past. These days machines do most of the trading, so the chart technicals have a lot of say. As bullish as gold story's is, GLD stock should correct. I am not calling for a complete collapse, but there are levels that need revisiting before any rally can proceed. * 7 Discount Retail Stocks to Buy for a Recession During the 2011 rally, experts called for gold prices to hit $2,200 per ounce. That marked the top and started a four-year correction. Furthermore, this rally merely brings gold to about the 50% retracement level of that correction. While I don't want to predict similar doom here, I expect GLD stock to revisit lower levels to build a better chart.Before you label me a perma-bear, I assure you that I prefer trading upside potential as it makes for happier and more positive attitudes. But the dip would give GLD the chance to build a better base for what ever future target it wants.A spike straight up leaves weak hands in control of GLD. So then at the sign of any trouble, the bulls become gutless and panic out of their positions. That is when trap doors open -- and the exit doors are never large enough to accommodate an orderly exit.In September, GLD stock corrected about 5% and is now is trying to shake it off. The short paid, but it is not yet clear that there is reason to stop shorting it here. If you are already short GLD, you can stay in it with proper stops. The Bottom Line on GLDFrom here, I expect GLD to head lower because it needs to retest $139 and $136 per share. This next statement will probably anger the gold bulls, but GLD stock should eventually fill the gap near $128 per share.In early June, the gold trade caught fire near $127. GLD rallied 16% from there with no retracement. Then September's dip came. There will be a fight between buyers and sellers near $140 for the control of the price action, so I expect a stall there.Next week is important for GLD. The Federal Reserve will make its decision on rates. If the Fed doesn't disappoint Wall Street then the markets will make new highs and it will be hard for gold bulls to maintain the rally. Conversely, if Fed Chairman Jerome Powell causes another equity market dip, then shorting GLD stock will be difficult.Since I can't control the headlines, I revert to charts to make decisions. The SPDR Gold Shares chart suggests that staying short here until the $140-zone fight ends is the right thing to do.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. Join his live chat room for free here. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Big IPO Stocks From 2019 to Watch * 7 Discount Retail Stocks to Buy for a Recession * 7 Stocks to Buy Benefiting From Millennial Money The post Stay Short in SPDR Gold Shares ETF appeared first on InvestorPlace.
- Zacks
Guide to 25 Most-Liquid ETFs
We highlight some ETFs that are being traded in ample volumes lately.
- PR Newswire
Selvita Announces First Patient Dosed in Phase 1b Study of CDK8 Inhibitor SEL120 in the Treatment of Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
KRAKOW, Poland, Sept. 6, 2019 /PRNewswire/ -- Selvita (SLV.WA) today announced that the first patient enrolled in the Phase 1b study of company's selective CDK8 inhibitor, SEL120, has received the first dose. SEL120 is being initially investigated in the treatment of patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS). This open-label, dose-escalation study is being conducted at multiple sites in the U.S. and evaluates the safety, tolerability and the preliminary activity of SEL120, as well as establishing a recommended dose for further clinical development.
- Zacks
Why Silver ETFs are Outshining Gold
Silver is regarded as a store of wealth and an alternative investment to risky assets during economic and political uncertainty.
- InvestorPlace
Stock Market Today: Hong Kong Saves the Day
Hong Kong's equities and its economy have been struggling over the past few months. If you thought trade tensions between the U.S. and China were high, those were nothing compared to what Hong Kong has been dealing with. Apparently -- and fortunately -- peace in Hong Kong goes a long way in the world, with global equities catching a nice boost. U.S. stocks enjoyed a solid session in the stock market today as well.The SPDR S&P 500 ETF (NYSEARCA:SPY) rose 1.1%, the SPDR Dow Jones Industrial Average (NYSEARCA:DIA) jumped 1% and PowerShares QQQ ETF (NASDAQ:QQQ) climbed 1.4%.InvestorPlace - Stock Market News, Stock Advice & Trading TipsAre we in the clear? First, Hong KongThe Hang Seng Index rallied 3.9% on the day -- its best day since 2011 -- after leader Carrie Lam withdrew the controversial extradition bill. The introduction of the bill ignited months of protests and billions around the globe watched the situation unfold. Those protests have intensified in recent weeks, causing many to wonder how it would conclude.Now we know, and that's one less thing to worry about. * The 8 Worst Stocks to Buy Before the Trade Turmoil Cools Off Given the uncertainty that the global economy is in, it's surprising the U.S. and China haven't hammered out a trade deal. The Hong Kong situation seems to be under control and if the trade deal would just come through, investors and business leaders would breathe a sigh of relief.It would also allow everyone to get back to business as usual. And if China and the U.S. are healthy, then almost everyone else is healthy, too. Gold and SilverOn Tuesday we detailed the likeliness of another interest rate cut from the Federal Reserve later this month. The market is fully pricing a cut from the Fed, and that can be seen in more than just forecasts.What does that mean? For one, silver and gold prices have been erupting. The iShares Silver Trust (NYSEARCA:SLV) and the SPDR Gold Shares (NYSEARCA:GLD) both hit new 52-week highs on Wednesday. SLV isn't all that far away from new multi-year highs, while gold is hitting its highest levels since 2013.While both appear overbought in the short term, there are several catalysts pushing them higher. Worries over the economy and increasing uncertainty always gets the blood going for gold bugs. But so too does central bank easing. The Fed cutting interest rates weakens the dollar. Lower rates and a weakening dollar is good for commodities like silver and gold, so it's no surprise we're seeing new highs lately. Movers in the Stock Market TodayAmerican Eagle Outfitters (NYSE:AEO) fell nearly 12% on Wednesday to new 52-week lows despite beating on earnings and revenue estimates, while Coupa (NASDAQ:COUP) rose almost 9% to new highs after crushing estimates and providing robust guidance.Lumber Liquidators (NYSE:LL) closed well off its highs of the day, but still climbed 9% after news of a go-private bid surfaced. Shares were as high as 16% on the day, but were unable to hold onto those gains. The news shouldn't be a complete surprise, as the former CEO took an equity stake in the company last month.Tyson Foods (NYSE:TSN) was once a relative strength leader in this market. However, its 7.8% fall on Wednesday took it off the go-to list for many bulls. Shares slid after the company announced a reduction to its full-year guidance. Heard on the StreetWorld Wrestling Entertainment (NYSE:WWE) was initiated with an "outperform" rating at Evercore ISI. The analyst also assigned a $90 price target to WWE, implying about 30% upside from the prior close. The analyst says the company has a path to "unprecedented growth."Roku (NASDAQ:ROKU) already has a buy-equivalent rating from DA Davidson, but the analysts took it a step further. They raised their $135 to price target to a Street-high $180. Roku is one of InvestorPlace's Top Stock Trades, and after finishing the session near $169, Davidson's rather bullish upgrade only leaves about 6% upside.Activision Blizzard (NASDAQ:ATVI) climbed 4.8% on Wednesday after analysts at BMO Capital Markets upgraded the stock to "outperform." They also gave a big boost to their price target, raising it from $43 to $60. The new target implies over 12% upside despite Wednesday's rally.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Deeply Discounted Energy Stocks to Buy * 7 Stocks to Buy In a Flat Market * 10 Stocks to Buy to Ride China's Emerging Wealth The post Stock Market Today: Hong Kong Saves the Day appeared first on InvestorPlace.
- InvestorPlace
5 Top Stock Trades for Thursday: ROKU, SBUX, SLV, LYFT, SQ
Global equity markets were in a good mood on Wednesday. As tensions eased in Hong Kong, equities took flight. It leaves investors wondering if the markets can start to go higher or if the seasonally tough September will still cause some swoons. Let's look at a few top stock trades. Top Stock Trades for Tomorrow 1: RokuOne stock that hasn't felt any swoon? Roku (NASDAQ:ROKU). This name has rallied so much this year it's incredible. The stock is up almost 450% in 2019 and many are wondering when the rally will end.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThat speculation likely only fuels the fire, but at some point it has to be true. * 10 Stocks to Buy for September Roku added another 8% at one point in Wednesday's session, surging to new all-time highs. The stock is now in nosebleed territory. I couldn't justify buying the name after this type of run, but that's easier to say after we've been pounding the table about Roku on InvestorPlace all year.On a pullback, ROKU may be worth a stab.Buyers stepped in at $130 last time. But when the stock is this hot, we just have to see where it ends up after it secures a high. Let's see if that comes this session, or in the next few. Top Stock Trades for Tomorrow 2: StarbucksRoku has been a relative strength machine, as has Starbucks (NASDAQ:SBUX). However, the latter was slipping in early Wednesday trading after the company's outlook disappointed investors.This one is interesting. On the plus side, investors bid up the name off its lows, which came on a near test of the 50-day moving average. On the downside, its ascending triangle pattern has failed to materialize.SBUX can still be friendly to longs, but will need to take out $97.50 on the upside. On the downside, watch the 50-day moving average and Wednesday's lows. Top Stock Trades for Tomorrow 3: LyftShares of Lyft (NASDAQ:LYFT) were all over the place on Wednesday, but in a good way. The stock opened higher on the day, but quickly took out Tuesday's low, making new 52-week lows.This was an excellent green-to-red trade, and one we were watching ahead of the open.However, LYFT then went positive on the day, giving investors an excellent two-way trade as it reversed higher. Nimble traders could short the green-to-red move and then buy the reversal.Investors who are long can use Wednesday's low as their stop and look for a rebound up toward $47.50, where it will find a notable level as well as channel resistance. Above it and a move to the 20-day moving average is possible. Top Stock Trades for Tomorrow 4: SilverThe iShares Silver Trust (NYSEARCA:SLV) ripped another 2% on Wednesday and while "ripped" may seem like an exaggerated description, consider the move over the past few weeks.Up eight of the last nine weeks, SLV has been a beast. Over $17.50 is significant, and opens the door to $18.90+. However, the ETF is quite overbought. That's not to say momentum can't continue, but it's something to consider for those looking at new positions.Those who are long may consider raising their stop losses. Top Stock Trades for Tomorrow 5: SquareDespite a bevy of upgrades, Square (NYSE:SQ) stock isn't trading all that well. The stock is now forming a series of lower highs (blue line), while support is noted at $60.Below $60 opens up the door to a decline down to $50, although buyers could step in before then too. * 7 Deeply Discounted Energy Stocks to Buy If SQ can push through downtrend resistance, the 20-day moving average is the first upside target, followed by the 200-day near $70.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell was long SBUX. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Deeply Discounted Energy Stocks to Buy * 7 Stocks to Buy In a Flat Market * 10 Stocks to Buy to Ride China's Emerging Wealth The post 5 Top Stock Trades for Thursday: ROKU, SBUX, SLV, LYFT, SQ appeared first on InvestorPlace.
- PR Newswire
Polish Financial Supervision Authority Approves Selvita CRO Prospectus, Allowing Corporate Split Into Two Separately Listed Companies to Proceed
KRAKOW, Poland, Sept. 3, 2019 /PRNewswire/ -- Selvita (SLV.WA) a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and development services, today announced that the Polish Financial Supervision Authority has approved the prospectus of Selvita CRO, a required step for the planned corporate split into two companies. One company will focus on the development of small molecule therapeutics in oncology and the other will provide contract research services.
- Investopedia
Silver Outpaces Gold as Investor Flee to Safe Havens
Silver prices reached fresh highs amid growing concern over the U.S.-China trade war and ongoing uncertainty surrounding Brexit.
- PR Newswire
Selvita to Present at Upcoming Conferences in September
KRAKOW , Poland , Sept. 3, 2019 /PRNewswire/ -- Selvita (WSE: SLV) today announced that Pawel Przewiezlikowski, Chief Executive Officer, will present at the following conferences in New York : Event: H.C. ...
